C

Chandra Bhagat Pharma Ltd
BSE:542934

Watchlist Manager
Chandra Bhagat Pharma Ltd
BSE:542934
Watchlist
Price: 41 INR 1.23% Market Closed
Market Cap: ₹309.6m

Operating Margin

-2.3%
Current
Declining
by 1.1%
vs 3-y average of -1.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.3%
=
Operating Income
₹-38.7m
/
Revenue
₹1.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.3%
=
Operating Income
₹-38.7m
/
Revenue
₹1.7B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Chandra Bhagat Pharma Ltd
BSE:542934
309.3m INR
Loading...
US
Mckesson Corp
NYSE:MCK
102.3B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
67.7B USD
Loading...
US
Cencora Inc
NYSE:COR
67.7B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
50B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.5B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.2B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.6B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66B HKD
Loading...

Market Distribution

Lower than 82% of companies in India
Percentile
18th
Based on 5 437 companies
18th percentile
-2.3%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Chandra Bhagat Pharma Ltd
Glance View

Market Cap
309.6m INR
Industry
Health Care

Chandra Bhagat Pharma Ltd. engages in the business of marketing pharmaceutical critical care & health care products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2020-02-14. The firm is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. The company is also engaged in the business of marketing pharmaceutical critical care & health care products. The company offers a wide range of product portfolio of pharmaceutical formulation including intravenous (IV) & intramuscular (IM) range injections, and a few tablets to cater the domestic & export market. The company has established presence in major therapeutic categories for formulations such as anticancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology etc. The company is engaged in promoting and marketing of active pharmaceuticals ingredients (API's) in India.

CBPL Intrinsic Value
Not Available
C
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-2.3%
=
Operating Income
₹-38.7m
/
Revenue
₹1.7B
What is Chandra Bhagat Pharma Ltd's current Operating Margin?

The current Operating Margin for Chandra Bhagat Pharma Ltd is -2.3%, which is below its 3-year median of -1.2%.

How has Operating Margin changed over time?

Over the last 3 years, Chandra Bhagat Pharma Ltd’s Operating Margin has decreased from 2.8% to -2.3%. During this period, it reached a low of -3.4% on Mar 31, 2024 and a high of 2.8% on Mar 3, 2022.

Back to Top